Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2186338rdf:typepubmed:Citationlld:pubmed
pubmed-article:2186338lifeskim:mentionsumls-concept:C2700280lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C0026447lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C1265472lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C0036055lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:2186338lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:2186338pubmed:issue3lld:pubmed
pubmed-article:2186338pubmed:dateCreated1990-6-14lld:pubmed
pubmed-article:2186338pubmed:abstractTextSaimiri and Aotus, two neotropical primates, are currently used in different domains of human malaria research. Here we present a simplified and non exhaustive enumeration of different aspects in concern of using these monkeys as experimental hosts, their availability, laboratory-bred animals versus wild-caught animals, their potential as experimental model in evaluating anti-malaria vaccine candidates, and some related activities at the Pasteur Institute.lld:pubmed
pubmed-article:2186338pubmed:languagefrelld:pubmed
pubmed-article:2186338pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2186338pubmed:citationSubsetIMlld:pubmed
pubmed-article:2186338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2186338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2186338pubmed:statusMEDLINElld:pubmed
pubmed-article:2186338pubmed:monthMarlld:pubmed
pubmed-article:2186338pubmed:issn0369-8114lld:pubmed
pubmed-article:2186338pubmed:authorpubmed-author:GysinJJlld:pubmed
pubmed-article:2186338pubmed:issnTypePrintlld:pubmed
pubmed-article:2186338pubmed:volume38lld:pubmed
pubmed-article:2186338pubmed:ownerNLMlld:pubmed
pubmed-article:2186338pubmed:authorsCompleteYlld:pubmed
pubmed-article:2186338pubmed:pagination189-92lld:pubmed
pubmed-article:2186338pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:meshHeadingpubmed-meshheading:2186338-...lld:pubmed
pubmed-article:2186338pubmed:year1990lld:pubmed
pubmed-article:2186338pubmed:articleTitle[Use of New World Saimiri and Aotus monkeys in the development of an anti-malaria vaccine].lld:pubmed
pubmed-article:2186338pubmed:affiliationLaboratoire d'Immunologie Parasitaire, Institut Pasteur de la Guyane Française, Cayenne.lld:pubmed
pubmed-article:2186338pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2186338pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:2186338pubmed:publicationTypeReviewlld:pubmed
pubmed-article:2186338pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed